Search
Genmab A/S
GMABAdd to Watchlist
25.270USD
-0.120-0.47%
Close 06/18, 16:00（ET）Quotes delayed by 15 min
15.56BMarket Cap
19.04P/E TTM
Revenue Breakdown
Currency: USDUpdated: Mon, Apr 6
Currency: USDUpdated: Mon, Apr 6
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
By BusinessUSD
Name
Revenue
Proportion
Royalties
3.10B
83.39%
Net product sales
398.00M
10.70%
Milestone payments
97.00M
2.61%
Collaboration revenue
70.00M
1.88%
Reimbursement income
53.00M
1.42%
By RegionUSD
Name
Revenue
Proportion
Denmark
3.33B
89.41%
Japan
213.00M
5.73%
U.S.A
180.00M
4.84%
Netherlands
1.00M
0.03%
China
0.00
0.00%
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Royalties
3.10B
83.39%
Net product sales
398.00M
10.70%
Milestone payments
97.00M
2.61%
Collaboration revenue
70.00M
1.88%
Reimbursement income
53.00M
1.42%
